Contemporary outcome measures in acute stroke research: Choice of primary outcome measure and statistical analysis of the primary outcome in acute stroke trials

Stroke

Volumn 43, Issue 4, 2012, Pages 935-937

  Tilley, Barbara C ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

acute stroke; modified Rankin Scale; outcomes; scales

Indexed keywords

ALTEPLASE;

ACUTE DISEASE; ACUTE STROKE; ANALYTICAL ERROR; CLINICAL TRIAL (TOPIC); CONSENSUS DEVELOPMENT; FIBRINOLYTIC THERAPY; HUMAN; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; STATISTICAL ANALYSIS; STROKE;

HUMANS; STROKE;

EID: 84859432503     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.644864     Document Type: Note

References (15)

1. Bath PM, Lees KR, Schellinger PD, Altman H, Bland M, Hogg C, et al, and for the European Stroke Organisation Outcomes Working Group; Statistical analysis of the primary outcome in acute stroke trials. Stroke. 2012;43:1171-1178
2. Lees KR, Bath PM, Schellinger PD, Kerr DM, Fulton R, Hacke W, et al, and for the European Stroke Organisation Outcomes Working Group. Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke. 2012;43:1163-1170
3. Tilley B, Marler J, Geller N, Lu M, Legler J, Brott T, et al. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke tPA trial. Stroke. 1996;27: 2136-2142 (Pubitemid 26372593)
4. Tilley BC, Huang P, O'Brien, PC. Global assessment variables. In: D'Agostino RB, Sullivan L, Massaro J, eds. Wiley Encyclopedia of Clinical Trials. New York: John Wiley & Sons, Inc; 2007
5. New PW, Buchbinder R. Critical appraisal and review of the Rankin Scale and its derivatives. Neuroepidemiology. 2006;26:4-15 (Pubitemid 41797932)
6. NINDS t-PS Stroke Study Group. Generalized efficacy of tPA for acute stroke: sub-group analyses of the NINDS tPA Stroke Trial. Stroke. 1997; 28:2119-2125
7. O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics. 1984;40:1079-1087
8. Huang P, Goetz CG, Woolson R, Tilley BC, Kerr D, Palesch Y, et al. for The Parkinson Study Group. Using global statistical tests in long term Parkinson's disease clinical trials. Mov Disord. 2009;24:1732-1739
9. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, et al. for the NINDS rtPA Stroke Study Group. Early stroke treatment associated with better outcome. Neurology. 2000;55:1649-1655
10. The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rtPA stroke trials. Lancet. 2004;363: 768-774
11. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. for the ECASS, ATLANTIS, NINDS, and EPITHET rt-PA Study Group Investigators. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703
12. Rankin J. Cerebral vascular accidents in patients over the age of 60: II. Prognosis. Scot Med J. 1957;2:200-215
13. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607
14. Candelise L, Pinardi G, Aritzu E, Musicco M. Telephone interview for stroke outcome assessment. Cerebrovasc Dis. 1994;4:341-343
15. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, et al. Movement Disorder Society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord. 2007;22:41-47. (Pubitemid 46382671)